Factors associated with recurrent hospital admissions for gout: A case-control study

Journal of Clinical Rheumatology

Volumn 15, Issue 6, 2009, Pages 271-274

  Hutton, Ingrid ^a,c   Gamble, Greg ^b   Gow, Peter ^a   Dalbeth, Nicola ^a,b  

^a Division of Medicine Emergency and Integrated Care   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c NONE   (New Zealand)

Author keywords

Allopurinol; Gout; Quality of health care

Indexed keywords

ACETYLSALICYLIC ACID; ALLOPURINOL; COLCHICINE; DIURETIC AGENT; URATE; URICOSURIC AGENT;

ADULT; ARTICLE; BLOOD LEVEL; CASE CONTROL STUDY; COMORBIDITY; CONTROLLED STUDY; DISEASE DURATION; DRUG USE; ETHNICITY; FEMALE; GOUT; HEART DISEASE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HYPERURICEMIA; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; RHEUMATOLOGY; RISK; SEX; URIC ACID BLOOD LEVEL;

ADULT; AGED; ALLOPURINOL; CASE-CONTROL STUDIES; COMORBIDITY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GOUT; GOUT SUPPRESSANTS; HEART DISEASES; HOSPITALIZATION; HUMANS; HYPERURICEMIA; MALE; MIDDLE AGED; NEW ZEALAND; PREVALENCE; QUALITY OF HEALTH CARE; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 70349092716     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/RHU.0b013e3181b562f8     Document Type: Article

References (21)

1. Yü TF, Gutman AB. Mobilization of gouty tophi by protracted use of uricosuric agents. Am J Med. 1951;11:765-769.
2. Perez-Ruiz F, Calabozo M, Pijoan JI, et al. Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout. Arthritis Rheum. 2002;47:356-360.
3. Sarawate C, Patel P, Schumacher H, et al. Serum urate levels and gout flares: analysis from managed care data. J Clin Rheumatol. 2006;12:61-65.
4. Shoji A, Yamanaka H, Kamatani N. A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy. Arthritis Rheum. 2004;51:321-325.
5. Zhang W, Doherty M, Pascual E, et al. EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2006;65:1312-1324. (Pubitemid 44620440)
6. Jordan KM, Cameron JS, Snaith M, et al. British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of gout. Rheumatology (Oxford). 2007;46:1372-1374.
7. Sundy JS, Becker MA, Schumacher HR, et al. Multicenter longitudinal study of disease characteristics in patients with treatment failure gout [abstract]. Ann Rheum Dis. 2006;65:272.
8. Sundy JS, Schumacher HR, Becker MA, et al. Quality of life in patients with treatment failure gout [abstract]. Ann Rheum Dis. 2006;65:271.
9. Wallace SL, Robinson H, Masi AT, et al. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum. 1977; 20:895-900.
10. Roddy E, Zhang W, Doherty M. Concordance of the management of chronic gout in a UK primary care population with the EULAR gout recommendations. Ann Rheum Dis. 2007;66:1311-1315.
11. Riedel AA, Nelson M, Joseph-Ridge N, et al. Compliance with allopurinol therapy among managed care enrollees with gout: a retrospective analysis of administrative claims. J Rheumatol. 2004;31:1575-1581.
12. Annemans L, Spaepen E, Nash C, et al. Gout in the UK and Germany: prevalence, comorbidities and management in general practice. Ann Rheum Dis. 2008;67:960-966.
13. Pérez-Ruiz F. Treatment of gout before rheumatology consultation is far from that recommended. Ann Rheum Dis. 2006;65 \([0-9]+\)(
14. Mikuls TR, Curtis JR, Allison JJ, et al. Medication errors with the use of allopurinol and colchicine: a retrospective study of a national, anonymous internet-accessible error reporting system. J Rheumatol. 2006;33:562-566.
15. Sarawate CA, Brewer KK, Yang W, et al. Gout medication treatment patterns and adherence to standards of care from a managed care perspective. Mayo Clin Proc. 2006;81:925-934.
16. Dalbeth N, Kumar S, Stamp L, et al. Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout. J Rheumatol. 2006;33:1646-1650.
17. Petersel D, Schlesinger N. Treatment of acute gout in hospitalized patients. J Rheumatol. 2007;34:7:1566-1568.
18. Prior IA, Rose BS. Uric acid, gout and public health in the South Pacific. NZ Med J. 1966;65:295-300.
19. Adams RJ, Smith BJ, Ruffin R. Factors associated with hospital admissions and repeat emergency department visits for adults with asthma. Thorax. 2000;55:566-573.
20. Hallerbach M, Francoeur A, Pomerantz S, et al. Patterns and predictors of early hospital readmission in patients with congestive heart failure. Am J Med Qual. 2008;23:18-23.
21. Marcantonio ER, McKean S, Goldfinger M, et al. Factors associated with unplanned hospital readmission among patients 65 years of age and older in a Medicare managed care plan. Am J Med. 1999;107:13-17.